GGrantIndex
← Search

CANCER PREVENTION AND CONTROL

$157,506P30FY2002CANIH

Sloan-Kettering Institute For Cancer Res, New York NY

Investigators

Linked publications, trials & patents

Trial NCT03699631Trial NCT02595918Trial NCT02417701Trial NCT02219737Trial NCT02152995Trial NCT01979523Trial NCT01947023Trial NCT01902160Trial NCT01705340Trial NCT01643278Trial NCT01638546Trial NCT01587352Trial NCT01585805Trial NCT01326702Trial NCT01281865Trial NCT01196416Trial NCT01154452Trial NCT01143402Trial NCT01119599Trial NCT01051557Trial NCT01026623Trial NCT01016015Trial NCT00957905Trial NCT00866177Trial NCT00729157Trial NCT00639509Trial NCT00601692Trial NCT00589472Trial NCT00570401Trial NCT00567229Trial NCT00550628Trial NCT00541034Trial NCT00528450Trial NCT00522301Trial NCT00521014Trial NCT00519974Trial NCT00514254Trial NCT00498927Trial NCT00483678Trial NCT00474994Trial NCT00471679Trial NCT00471601Trial NCT00470574Trial NCT00470470Trial NCT00462982Trial NCT00462501Trial NCT00459875Trial NCT00458705Trial NCT00453310Trial NCT00450827Trial NCT00416351Trial NCT00404365Trial NCT00398138Trial NCT00397904Trial NCT00369174Trial NCT00354679Trial NCT00334893Trial NCT00324480Trial NCT00245102Trial NCT00104845Trial NCT00090337Trial NCT00089245Trial NCT00087009Trial NCT00072345Trial NCT00072319Trial NCT00070057Trial NCT00067015Trial NCT00062374Trial NCT00059891Trial NCT00058253Trial NCT00054132Trial NCT00046917Trial NCT00040898Trial NCT00040872Trial NCT00039286Trial NCT00037011Trial NCT00036933Trial NCT00028730Trial NCT00024258Trial NCT00023764Trial NCT00020891Trial NCT00016146Trial NCT00014534Trial NCT00014469Trial NCT00008294Trial NCT00008242Trial NCT00006044Trial NCT00004245Trial NCT00004066Trial NCT00003923Trial NCT00003819Trial NCT00003173Trial NCT00003023Trial NCT00002981Trial NCT00002930Trial NCT00002766Trial NCT00002738Trial NCT00002718Trial NCT00002663Trial NCT00002558

Abstract

Description: The Cancer Prevention and Control Research Program is a reorganized version of a program presented in the last CCSG renewal. It is directed by Dr. Sidney Winawer, with Dr. Kenneth Offit listed as Vice Chairman. The application lists 54 members, with a total of approximately $10 million in research support. The research activity in the program is divided into seven major research "projects" or focus areas, each of which has one or more senior leaders. Three specific aims are described for this program that are diversely related to cancer prevention and control activity through studies at the genetic, environmental and behavioral levels. Scientific directions for the program are monitored by an advisory committee that interacts closely with MSKCC's Research Council. The specific research projects in this program include: colorectal cancer prevention (Winawer), epidemiology research (Begg), human genetics research (Chaganti, Luzzatto, and Offit), molecular pathology research (Cordon-Cardo), nutrition and chemoprevention (Shike), pain and palliative care (Foley and Portenoy), and psychiatry and behavioral sciences research (Holland). This organizational structure reflects a change since the last renewal by inclusion of the human genetics research group, the addition of Dr. Offit as Vice Chairman, and the inclusion of the molecular pathology and cancer genetics research activities. The application describes these multidisciplinary elements and their relationship to the specific aims of the program in detail. A common theme related to the recent investments and recruitments in human genetics is described. Cancer prevention and control research, in particular populationbased studies, are described as a high priority for the Center.

View original record on NIH RePORTER →
CANCER PREVENTION AND CONTROL · GrantIndex